For the Inventor, By the Inventor

Enter assignee name

Cipla Limited

USPTO Granted Patents = 177

CIPO Patents = 8

EPO Patents = 59

Trademarks = 14

Forward Citations = 488

Loading Chart...

Loading Chart...

80 inventors (with patents filed for the assignee):

Dharmaraj Ramachandra Rao (87 out of 88 patents)

Rajendra Narayanrao Kankan (85 out of 85 patents)

Geena Malhotra (70 out of 78 patents)

4. Amar Lulla (35 out of 38 patents)

5. Srinivas Laxminarayan Pathi (29 out of 29 patents)

6. Kalpana Sanjay Joshi (23 out of 38 patents)

7. Manjinder Singh Phull (20 out of 20 patents)

8. Xerxes Rao (16 out of 18 patents)

9. Maruti Ganpati Ghagare (16 out of 16 patents)

10. Jeevan Ghosalkar (14 out of 17 patents)

11. Dilip Ramdas Birari (13 out of 13 patents)

12. Sarabjit Singh (12 out of 14 patents)

13. Manish Gopaldas Gangrade (8 out of 8 patents)

14. Ravikumar Puppala (8 out of 8 patents)

15. Shrinivas Madhukar Purandare (7 out of 7 patents)

Core Competencies:

Pharmaceutical Compositions

Polymorphs

Bruton's Tyrosine Kinase Inhibitor

Intranasal Formulation

Adherence-Tracking Device

Stable Formulations

Combination Therapy

Antiviral Phosphonate Analogues

Nasal Spray Assembly

Cancer Treatment

Hepatitis C Treatment

Depot Formulation

177 patents: Sort by Forward Citations

1. 12472190 - Pharmaceutical compositions (2025-11-18),

2. 12384784 - Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor (2025-08-12),

3. 12324811 - Intranasal formulation (2025-06-10),

4. 12213798 - Adherence-tracking and monitoring device for metered-dose inhaler (2025-02-04),

5. 12195480 - Polymorphs of integrase inhibitor (2025-01-14),

6. 12109270 - Rifaximin complexes (2024-10-08),

7. 12109200 - Rifaximin (2024-10-08),

8. 12090163 - Pharmaceutical compositions (2024-09-17),

9. 12036358 - Single blister-strip based dispenser (2024-07-16),

10. 11931362 - Stable pharmaceutical formulations of pemetrexed (2024-03-19),

11. 11612612 - Pharmaceutical compositions (2023-03-28),

12. 11596597 - Depot formulation (2023-03-07),

13. 11478483 - Method of treating hypertension (2022-10-25),

14. 11464425 - Flow sensing arrangement for spirometer and method thereof (2022-10-11),

15. 11390637 - Salts of antiviral phosphonate analogues and process for preparation thereof (2022-07-19),

Cipla Limited is a leading global pharmaceutical company headquartered in Mumbai, India. Founded in 1935, Cipla is dedicated to providing high-quality and affordable healthcare solutions worldwide. It primarily focuses on developing and manufacturing medicines for respiratory, cardiovascular, anti-infective, CNS, and other therapeutic segments. Cipla operates in over 80 countries and has a strong presence in both developed and emerging markets. Through innovative research and development, Cipla aims to make healthcare accessible to all.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

177 Patents

#3 in Mumbai

#8 in India

#4,581 in the World

Cipla Limited

Forward Citations = 488

80 inventors:

Dharmaraj Ramachandra Rao (87 out of 88 patents)

Rajendra Narayanrao Kankan (85 out of 85 patents)

Geena Malhotra (70 out of 78 patents)

4. Amar Lulla (35 out of 38 patents)

5. Srinivas Laxminarayan Pathi (29 out of 29 patents)

Please report any incorrect information to support@idiyas.com

Loading…